Hinova Pharmaceuticals Inc. (SHA:688302)
China
· Delayed Price · Currency is CNY 42.60
+1.98 (4.87%)
At close: Mar 6, 2026
Hinova Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -199.5 | -294.16 | -301.51 | -306.18 | Upgrade
|
| Depreciation & Amortization | - | 5.97 | 6.42 | 5.47 | 3.05 | Upgrade
|
| Other Amortization | - | 0.04 | 0.04 | 0.04 | 0.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | 0.01 | 0 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -13.11 | -24.83 | -28.89 | -23.56 | Upgrade
|
| Other Operating Activities | - | -3.66 | -2.78 | -3.3 | 6.05 | Upgrade
|
| Change in Accounts Receivable | - | 5.92 | 5.76 | 4.04 | 3.96 | Upgrade
|
| Change in Inventory | - | 0 | 0 | -0 | -0 | Upgrade
|
| Change in Accounts Payable | - | -7.54 | -21.85 | -93.6 | -20.6 | Upgrade
|
| Change in Other Net Operating Assets | - | 24.79 | 75.88 | 102.82 | 108.82 | Upgrade
|
| Operating Cash Flow | - | -187.08 | -255.51 | -314.92 | -227.82 | Upgrade
|
| Capital Expenditures | - | -89.55 | -99.18 | -69.21 | -19.77 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 0.02 | 0 | - | Upgrade
|
| Investment in Securities | - | 80 | -25 | -370 | - | Upgrade
|
| Other Investing Activities | - | -20.7 | 24.83 | 29.31 | 23.2 | Upgrade
|
| Investing Cash Flow | - | -30.25 | -99.33 | -409.9 | 3.42 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.5 | 30 | - | Upgrade
|
| Total Debt Issued | - | - | 0.5 | 30 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -30.5 | - | -0.5 | Upgrade
|
| Long-Term Debt Repaid | - | -4.06 | -4.39 | -3.4 | -1.56 | Upgrade
|
| Total Debt Repaid | - | -4.06 | -34.89 | -3.4 | -2.06 | Upgrade
|
| Net Debt Issued (Repaid) | - | -4.06 | -34.39 | 26.6 | -2.06 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,010 | - | Upgrade
|
| Common Dividends Paid | - | - | -0.9 | - | -2.56 | Upgrade
|
| Other Financing Activities | - | - | - | -19.31 | -3.86 | Upgrade
|
| Financing Cash Flow | - | -4.06 | -35.29 | 1,017 | -8.48 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1.43 | 1.75 | 7.8 | -1.99 | Upgrade
|
| Net Cash Flow | - | -219.96 | -388.38 | 300.38 | -234.87 | Upgrade
|
| Free Cash Flow | - | -276.63 | -354.68 | -384.13 | -247.6 | Upgrade
|
| Free Cash Flow Margin | - | -75410.46% | - | -23269.07% | - | Upgrade
|
| Free Cash Flow Per Share | - | -2.79 | -3.58 | -4.23 | -3.33 | Upgrade
|
| Cash Interest Paid | - | - | - | 3.92 | - | Upgrade
|
| Cash Income Tax Paid | - | 0.44 | -19.4 | -13.46 | -6.07 | Upgrade
|
| Levered Free Cash Flow | - | 268.67 | -230.86 | -252.88 | -145.13 | Upgrade
|
| Unlevered Free Cash Flow | - | 269 | -229.93 | -250.43 | -143.54 | Upgrade
|
| Change in Working Capital | - | 23.17 | 59.79 | 13.27 | 92.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.